SCINAI IMMUNOTHERAPEUTICS LTD. Increase Decrease Through Exercise Of Warrants Equity
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Increase Decrease Through Exercise Of Warrants Equity of ILS 45.27 million for the 9-month period ending 2020-09-30, per its 6-K filed 2021-01-28.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2021-01-28
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease through exercise of warrants equity for the quarter ending 2020-09-30 was 0.00 ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease through exercise of warrants equity for the quarter ending 2020-06-30 was 38.03M ILS.
| Period end | Increase Decrease Through Exercise Of Warrants Equity 3 month | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 9 month |
|---|---|---|---|
| 2020-09-30 | 0.00 ILS derived: 6-K 9 month − 6-K 6 month · filed 2021-01-28 | 38.03M ILS derived: sum of 2 quarters · filed 2021-01-28 | 45.27M ILS 6-K · filed 2021-01-28 |
| 2020-06-30 | 38.03M ILS 6-K · filed 2020-10-02 | 45.27M ILS 6-K · filed 2020-10-02 |